Entering text into the input field will update the search result below

Equillium acquires Metacrine to extend cash runway through 2024

word m and a made with wood building blocks, stock image

Maksim Labkouski

  • Equillium (NASDAQ:EQ) announced Tuesday the definitive deal to acquire Metacrine (NASDAQ:MTCR) in an all-stock transaction.
  • The acquisition is estimated to add $33M in cash to Equillium’s balance sheet at closing, which is expected to extend the company’s cash runway into 2024.

Recommended For You

Related Stocks

SymbolLast Price% Chg
EQ
--
MTCR
--